Acadian Asset Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-281
| Closed | -$5K | – | 1846 |
|
2024
Q4 | $5K | Sell |
281
-983
| -78% | -$17.5K | ﹤0.01% | 1572 |
|
2024
Q3 | $13K | Sell |
1,264
-6,161
| -83% | -$63.4K | ﹤0.01% | 2019 |
|
2024
Q2 | $68K | Sell |
7,425
-1,859
| -20% | -$17K | ﹤0.01% | 1578 |
|
2024
Q1 | $303K | Sell |
9,284
-729
| -7% | -$23.8K | ﹤0.01% | 1113 |
|
2023
Q4 | $266K | Buy |
10,013
+3,661
| +58% | +$97.3K | ﹤0.01% | 1177 |
|
2023
Q3 | $383K | Buy |
+6,352
| New | +$383K | ﹤0.01% | 1074 |
|
2021
Q3 | – | Sell |
-853
| Closed | -$438K | – | 2067 |
|
2021
Q2 | $438K | Buy |
853
+669
| +364% | +$344K | ﹤0.01% | 1193 |
|
2021
Q1 | $145K | Buy |
+184
| New | +$145K | ﹤0.01% | 1587 |
|